DOCSLIB.ORG

Mouse Tnip2 Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Tnip2 Knockout Project (CRISPR/Cas9) http://www.alphaknockout.com/ Mouse Tnip2 Knockout Project (CRISPR/Cas9) Objective: To create a Tnip2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Tnip2 gene (NCBI Reference Sequence: NM_139064 ; Ensembl: ENSMUSG00000059866 ) is located on Mouse chromosome 5. 6 exons are identified , with the ATG start codon in exon 1 and the TGA stop codon in exon 6 (Transcript: ENSMUST00000087737). Exon 3~5 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mice homozygous for a null allele have impaired IL-1 response and macrophage physiology. Exon 3 starts from about 44.26% of the coding region. Exon 3~5 covers 35.58% of the coding region. The size of effective KO region: ~1818 bp. The KO region does not have any other known gene. Page 1 of 9 http://www.alphaknockout.com/ Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 3 4 5 6 Legends Exon of mouse Tnip2 Knockout region Page 2 of 9 http://www.alphaknockout.com/ Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 3 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section downstream of Exon 5 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 9 http://www.alphaknockout.com/ Overview of the GC Content Distribution (up) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(24.65% 493) | C(21.6% 432) | G(26.4% 528) | T(27.35% 547) Note: The 2000 bp section upstream of Exon 3 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution (down) Window size: 300 bp Sequence 12 Summary: Full Length(2000bp) | A(23.2% 464) | C(22.65% 453) | G(24.85% 497) | T(29.3% 586) Note: The 2000 bp section downstream of Exon 5 is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 4 of 9 http://www.alphaknockout.com/ BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr5 - 34500998 34502997 2000 browser details YourSeq 46 611 751 2000 87.1% chr13 - 26935381 26935527 147 browser details YourSeq 41 542 588 2000 95.6% chr17 + 83903052 83903101 50 browser details YourSeq 31 722 759 2000 97.0% chr14 + 79332495 79332534 40 browser details YourSeq 29 555 589 2000 93.8% chr3 + 129242831 129242865 35 browser details YourSeq 26 555 589 2000 88.3% chr15 - 53684693 53684731 39 browser details YourSeq 26 862 890 2000 96.6% chr6 + 107243116 107243146 31 browser details YourSeq 24 1823 1846 2000 100.0% chr15 - 21704518 21704541 24 browser details YourSeq 23 660 756 2000 61.9% chr16 - 89777601 89777697 97 browser details YourSeq 23 206 228 2000 100.0% chr13 - 30969314 30969336 23 browser details YourSeq 23 91 113 2000 100.0% chr1 + 36375109 36375131 23 browser details YourSeq 22 618 643 2000 92.4% chr2 + 37683429 37683454 26 browser details YourSeq 22 864 886 2000 100.0% chr10 + 78797897 78797921 25 browser details YourSeq 21 1821 1841 2000 100.0% chr13 - 100955556 100955576 21 browser details YourSeq 21 1821 1841 2000 100.0% chr13 - 24673356 24673376 21 browser details YourSeq 21 797 817 2000 100.0% chr11 - 76593081 76593101 21 browser details YourSeq 21 715 735 2000 100.0% chr9 + 26527626 26527646 21 browser details YourSeq 21 139 159 2000 100.0% chr2 + 140199626 140199646 21 browser details YourSeq 20 139 158 2000 100.0% chr1 - 34412080 34412099 20 Note: The 2000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 2000 1 2000 2000 100.0% chr5 - 34497180 34499179 2000 browser details YourSeq 43 1202 1621 2000 59.6% chr5 + 76263672 76263842 171 browser details YourSeq 40 1141 1227 2000 97.8% chr19 - 8940141 8940241 101 browser details YourSeq 33 1194 1229 2000 97.3% chr15 + 42513416 42513452 37 browser details YourSeq 33 1193 1229 2000 97.3% chr14 + 54548260 54548298 39 browser details YourSeq 32 1196 1230 2000 97.1% chr9 + 103157104 103157139 36 browser details YourSeq 32 1192 1225 2000 100.0% chr17 + 61579186 61579224 39 browser details YourSeq 32 1196 1229 2000 100.0% chr12 + 70852297 70852332 36 browser details YourSeq 31 1195 1230 2000 94.3% chr18 - 41365619 41365656 38 browser details YourSeq 31 1195 1229 2000 91.0% chr18 - 28215170 28215203 34 browser details YourSeq 31 1191 1229 2000 91.5% chr16 + 52196071 52196126 56 browser details YourSeq 30 1195 1230 2000 81.9% chr17 - 57120511 57120543 33 browser details YourSeq 30 1195 1230 2000 94.2% chr13 - 17060186 17060224 39 browser details YourSeq 30 1192 1226 2000 94.0% chr15 + 94043472 94043506 35 browser details YourSeq 30 1195 1227 2000 87.1% chr15 + 75303812 75303842 31 browser details YourSeq 30 1194 1226 2000 87.1% chr1 + 17434941 17434971 31 browser details YourSeq 29 1195 1227 2000 90.4% chrX - 45521396 45521427 32 browser details YourSeq 29 1198 1229 2000 96.8% chr7 - 57251061 57251092 32 browser details YourSeq 29 1202 1231 2000 100.0% chr3 - 115400763 115400793 31 browser details YourSeq 29 1193 1228 2000 84.4% chr2 + 79062738 79062771 34 Note: The 2000 bp section downstream of Exon 5 is BLAT searched against the genome. No significant similarity is found. Page 5 of 9 http://www.alphaknockout.com/ Gene and protein information: Tnip2 TNFAIP3 interacting protein 2 [ Mus musculus (house mouse) ] Gene ID: 231130, updated on 10-Oct-2019 Gene summary Official Symbol Tnip2 provided by MGI Official Full Name TNFAIP3 interacting protein 2 provided by MGI Primary source MGI:MGI:2386643 See related Ensembl:ENSMUSG00000059866 Gene type protein coding RefSeq status PROVISIONAL Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as ABIN-2; AI428870; 1810020H16Rik Expression Ubiquitous expression in adrenal adult (RPKM 22.5), ovary adult (RPKM 19.9) and 28 other tissues See more Orthologs human all Genomic context Location: 5; 5 B2 See Tnip2 in Genome Data Viewer Exon count: 6 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 5 NC_000071.6 (34496096..34513979, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 5 NC_000071.5 (34838745..34856628, complement) Chromosome 5 - NC_000071.6 Page 6 of 9 http://www.alphaknockout.com/ Transcript information: This gene has 6 transcripts Gene: Tnip2 ENSMUSG00000059866 Description TNFAIP3 interacting protein 2 [Source:MGI Symbol;Acc:MGI:2386643] Gene Synonyms 1810020H16Rik, ABIN-2 Location Chromosome 5: 34,496,087-34,513,991 reverse strand. GRCm38:CM000998.2 About this gene This gene has 6 transcripts (splice variants), 161 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 1 phenotype. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Tnip2-202 ENSMUST00000087737.9 1987 430aa ENSMUSP00000085030.3 Protein coding CCDS19214 Q99JG7 TSL:1 GENCODE basic APPRIS P1 Tnip2-201 ENSMUST00000030991.13 2022 451aa ENSMUSP00000030991.7 Protein coding - Q80VZ7 TSL:1 GENCODE basic Tnip2-203 ENSMUST00000114359.1 1642 347aa ENSMUSP00000109999.1 Protein coding - D3Z039 TSL:5 GENCODE basic Tnip2-204 ENSMUST00000137555.1 900 No protein - Retained intron - - TSL:3 Tnip2-206 ENSMUST00000159102.1 584 No protein - Retained intron - - TSL:2 Tnip2-205 ENSMUST00000143072.1 383 No protein - Retained intron - - TSL:3 Page 7 of 9 http://www.alphaknockout.com/ 37.91 kb Forward strand 34.49Mb 34.50Mb 34.51Mb 34.52Mb Genes Fam193a-202 >protein coding (Comprehensive set... Gm43457-201 >TEC Contigs < AC102620.11 < AC115695.11 Genes (Comprehensive set... < Tnip2-202protein coding < Tnip2-201protein coding < Tnip2-203protein coding < Tnip2-205retained intron < Tnip2-204retained intron < Tnip2-206retained intron Regulatory Build 34.49Mb 34.50Mb 34.51Mb 34.52Mb Reverse strand 37.91 kb Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Page 8 of 9 http://www.alphaknockout.com/ Transcript: ENSMUST00000030991 < Tnip2-201protein coding Reverse strand 17.88 kb ENSMUSP00000030... MobiDB lite Low complexity (Seg) Coiled-coils (Ncoils) Pfam TSG101 and ALIX binding domain of CEP55 NF-kappa-B essential modulator NEMO, CC2-LZ domain PROSITE profiles NEMO, Zinc finger PANTHER PTHR31882 PTHR31882:SF10 Gene3D 1.20.5.990 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 320 360 400 451 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC, VectorBuilder. Page 9 of 9.
Load more

Recommended publications
  • Cytogenomic SNP Microarray - Fetal ARUP Test Code 2002366 Maternal Contamination Study Fetal Spec Fetal Cells
    Patient Report |FINAL Client: Example Client ABC123 Patient: Patient, Example 123 Test Drive Salt Lake City, UT 84108 DOB 2/13/1987 UNITED STATES Gender: Female Patient Identifiers: 01234567890ABCD, 012345 Physician: Doctor, Example Visit Number (FIN): 01234567890ABCD Collection Date: 00/00/0000 00:00 Cytogenomic SNP Microarray - Fetal ARUP test code 2002366 Maternal Contamination Study Fetal Spec Fetal Cells Single fetal genotype present; no maternal cells present. Fetal and maternal samples were tested using STR markers to rule out maternal cell contamination. This result has been reviewed and approved by Maternal Specimen Yes Cytogenomic SNP Microarray - Fetal Abnormal * (Ref Interval: Normal) Test Performed: Cytogenomic SNP Microarray- Fetal (ARRAY FE) Specimen Type: Direct (uncultured) villi Indication for Testing: Patient with 46,XX,t(4;13)(p16.3;q12) (Quest: EN935475D) ----------------------------------------------------------------- ----- RESULT SUMMARY Abnormal Microarray Result (Male) Unbalanced Translocation Involving Chromosomes 4 and 13 Classification: Pathogenic 4p Terminal Deletion (Wolf-Hirschhorn syndrome) Copy number change: 4p16.3p16.2 loss Size: 5.1 Mb 13q Proximal Region Deletion Copy number change: 13q11q12.12 loss Size: 6.1 Mb ----------------------------------------------------------------- ----- RESULT DESCRIPTION This analysis showed a terminal deletion (1 copy present) involving chromosome 4 within 4p16.3p16.2 and a proximal interstitial deletion (1 copy present) involving chromosome 13 within 13q11q12.12. This
    [Show full text]
  • Expression Level and Prognostic Potential of MAP3K8 in Human Cancers Based on Data Mining
    Expression Level and Prognostic Potential of MAP3K8 in Human Cancers Based on Data Mining Jiatao Hao Xi'an Jiaotong University Medical College First Aliated Hospital Yumeng Cao China Medical University Hui Yu Xi'an Jiaotong University Medical College First Aliated Hospital Lu Zong Xi'an Jiaotong University Medical College First Aliated Hospital Ruifang An Xi'an Jiaotong University Medical College First Aliated Hospital Yan Xue ( [email protected] ) Xi'an Jiaotong University Medical College First Aliated Hospital https://orcid.org/0000-0002-6061- 1706 Primary research Keywords: MAPK kinase kinase 8 (MAP3K8), expression, methylation, prognosis, protein-protein interaction (PPI), functional enrichment analysis Posted Date: March 9th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-276370/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/22 Abstract Background: MAPK kinase kinase 8 (MAP3K8) is a member of the MAP3K family with a major role in the regulation of the MAPK pathway and immune response. Differential expression of MAP3K8 is closely correlated with tumorigenesis. In this study, we used bioinformatics tools to explore expression level, prognostic values, and interactive networks of MAP3K8 in human cancers. Methods: Expression prole of MAP3K8 was analyzed using the Oncomine Platform, the Gene Expression Proling Interactive Analysis (GEPIA), and UALCAN. Survival analysis was evaluated via UALCAN, GEPIA, and DriverDBv3 databases. Then, MAP3K8 related functional networks were explored within GeneMANIA and Cytoscape. Moreover, Metascape was used to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Results: We found that MAP3K8 was down-expressed in most cancer samples compared with paired normal tissues.
    [Show full text]
  • Genome-Wide Analysis of Differential Transcriptional and Epigenetic
    bioRxiv preprint doi: https://doi.org/10.1101/083246; this version posted October 26, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Genome-wide Analysis of Differential Transcriptional and 2 Epigenetic Variability Across Human Immune Cell Types 3 Simone Ecker,1,2,* Lu Chen,3,4 Vera Pancaldi,1 Frederik O. Bagger,4,5,6 José María Fernández,1 Enrique Carrillo de 4 Santa Pau,1 David Juan,1 Alice L. Mann,3 Stephen Watt,3 Francesco Paolo Casale,6 Nikos Sidiropoulos,7,8,9 Nicolas 5 Rapin,7,8,9 Angelika Merkel,10 BLUEPRINT Consortium, Henk Stunnenberg,11 Oliver Stegle,6 Mattia Frontini,4,5,12 Kate 6 Downes,4,5 Tomi Pastinen,13 Taco W. Kuijpers,14,15 Daniel Rico,1,17 Alfonso Valencia,1,17 Stephan Beck,2,17 Nicole 7 Soranzo3,4,17,* and Dirk S. Paul2,16,17,* 8 9 1Structural Biology and Biocomputing Programme, Spanish National Cancer Research Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain 10 2UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK 11 3Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1HH, UK 12 4Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Long Road, Cambridge, CB2 0PT, UK 13 5National Health Service (NHS) Blood and Transplant, Cambridge Biomedical Campus, Long Road, Cambridge, CB2
    [Show full text]
  • KLF6 Depletion Promotes NF-Κb Signaling in Glioblastoma
    OPEN Oncogene (2017) 36, 3562–3575 www.nature.com/onc ORIGINAL ARTICLE KLF6 depletion promotes NF-κB signaling in glioblastoma AP Masilamani1,2, R Ferrarese1,2, E Kling1,2, NK Thudi3, H Kim4, DM Scholtens5, F Dai1,2, M Hadler1,2, T Unterkircher1,2, L Platania1,2, A Weyerbrock1,2, M Prinz6,7, GY Gillespie8, GR Harsh IV9, M Bredel3,10 and MS Carro1,2,10 Dysregulation of the NF-κB transcription factor occurs in many cancer types. Krüppel-like family of transcription factors (KLFs) regulate the expression of genes involved in cell proliferation, differentiation and survival. Here, we report a new mechanism of NF- κB activation in glioblastoma through depletion of the KLF6 tumor suppressor. We show that KLF6 transactivates multiple genes negatively controlling the NF-κB pathway and consequently reduces NF-κB nuclear localization and downregulates NF-κB targets. Reconstitution of KLF6 attenuates their malignant phenotype and induces neural-like differentiation and senescence, consistent with NF-κB pathway inhibition. KLF6 is heterozygously deleted in 74.5% of the analyzed glioblastomas and predicts unfavorable patient prognosis suggesting that haploinsufficiency is a clinically relevant means of evading KLF6-dependent regulation of NF-κB. Together, our study identifies a new mechanism by which KLF6 regulates NF-κB signaling, and how this mechanism is circumvented in glioblastoma through KLF6 loss. Oncogene (2017) 36, 3562–3575; doi:10.1038/onc.2016.507; published online 6 February 2017 INTRODUCTION coding region have been controversial.16,18–22 KLF6 has been The NF-κB transcription factor family is oncogenic through proposed to perform its tumor suppression function by promoting suppression of programmed cell death, and promotion of tumor G1 cell cycle arrest mainly through cyclin-dependent kinase 15 growth and invasion.1 In tumors, NF-κB can be activated by inhibitor 1A (CDKN1A) promoter transactivation.
    [Show full text]
  • SUPPLEMENTARY METHODS Cell Culture.-Human Peripheral Blood
    SUPPLEMENTARY METHODS Cell culture.-Human peripheral blood mononuclear cells (PBMC) were isolated from buffy coats from normal donors over a Lymphoprep (Nycomed Pharma) gradient. Monocytes were purified from PBMC by magnetic cell sorting using CD14 microbeads (Miltenyi Biotech). Monocytes were cultured at 0.5 x 106 cells/ml for 7 days in RPMI 1640 (standard RPMI, which contains 1 mg/L folic acid) supplemented with 10% fetal calf serum, at 37ºC in a humidified atmosphere with 5% CO2, and containing GM-CSF (1000U/ml) or M-CSF (10 ng/ml, ImmunoTools) to generate GM-CSF- polarized macrophages (GM-MØ) or M-CSF-polarized macrophages (M-MØ). MTX pharmacokinetic studies in RA patients administered 25 mg MTX showed peak plasma levels of 1-2 µM MTX two hours after drug administration, but plasma levels decline to 10-50 nM MTX within 24-48 hours [1, 2]. MTX (50 nM), pemetrexed (PMX, 50 nM), folic acid (FA, 50 nM) [3], thymidine (dT, 10 µM), pifithrin-α (PFT, 25-50 µM), nutlin-3 (10 µM, Sigma-Aldrich) was added once on monocytes together with the indicated cytokine, or on monocytes and 7-day differentiated macrophages for 48h. Gene expression profiling.-For long-term MTX treatment, RNA was isolated from three independent preparations of monocytes either unexposed or exposed to MTX (50 nM) and differentiated to GM-MØ or M-MØ for 7-days. For short-term schedule, RNA was isolated from three independent samples of fully differentiated GM-MØ either unexposed or exposed to MTX (50 nM) for 48h, by using RNeasy Mini kit (QIAGEN).
    [Show full text]
  • Nephritis Responses in Murine and Human Lupus Analysis Defines
    Downloaded from http://www.jimmunol.org/ by guest on October 2, 2021 is online at: average * The Journal of Immunology , 24 of which you can access for free at: 2012; 189:988-1001; Prepublished online 20 June from submission to initial decision 4 weeks from acceptance to publication Celine C. Berthier, Ramalingam Bethunaickan, Tania Gonzalez-Rivera, Viji Nair, Meera Ramanujam, Weijia Zhang, Erwin P. Bottinger, Stephan Segerer, Maja Lindenmeyer, Clemens D. Cohen, Anne Davidson and Matthias Kretzler 2012; doi: 10.4049/jimmunol.1103031 http://www.jimmunol.org/content/189/2/988 Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis J Immunol cites 60 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/189/2/988.full#ref-list-1 http://www.jimmunol.org/content/suppl/2012/06/20/jimmunol.110303 1.DC1 This article Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 2, 2021. The Journal of Immunology Cross-Species Transcriptional Network Analysis Defines Shared Inflammatory Responses in Murine and Human Lupus Nephritis Celine C.
    [Show full text]
  • The Genetic Factors of Bilaterian Evolution Peter Heger1*, Wen Zheng1†, Anna Rottmann1, Kristen a Panfilio2,3, Thomas Wiehe1
    RESEARCH ARTICLE The genetic factors of bilaterian evolution Peter Heger1*, Wen Zheng1†, Anna Rottmann1, Kristen A Panfilio2,3, Thomas Wiehe1 1Institute for Genetics, Cologne Biocenter, University of Cologne, Cologne, Germany; 2Institute for Zoology: Developmental Biology, Cologne Biocenter, University of Cologne, Cologne, Germany; 3School of Life Sciences, University of Warwick, Gibbet Hill Campus, Coventry, United Kingdom Abstract The Cambrian explosion was a unique animal radiation ~540 million years ago that produced the full range of body plans across bilaterians. The genetic mechanisms underlying these events are unknown, leaving a fundamental question in evolutionary biology unanswered. Using large-scale comparative genomics and advanced orthology evaluation techniques, we identified 157 bilaterian-specific genes. They include the entire Nodal pathway, a key regulator of mesoderm development and left-right axis specification; components for nervous system development, including a suite of G-protein-coupled receptors that control physiology and behaviour, the Robo- Slit midline repulsion system, and the neurotrophin signalling system; a high number of zinc finger transcription factors; and novel factors that previously escaped attention. Contradicting the current view, our study reveals that genes with bilaterian origin are robustly associated with key features in extant bilaterians, suggesting a causal relationship. *For correspondence: [email protected] Introduction The taxon Bilateria consists of multicellular animals
    [Show full text]
  • The Roles of Trim15 and UCHL3 in the Ubiquitin-Mediated Cell Cycle Regulation Katerina Jerabkova
    The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation Katerina Jerabkova To cite this version: Katerina Jerabkova. The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation. Cellular Biology. Université de Strasbourg; Univerzita Karlova (Prague), 2019. English. NNT : 2019STRAJ034. tel-02884583 HAL Id: tel-02884583 https://tel.archives-ouvertes.fr/tel-02884583 Submitted on 30 Jun 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTÉ IGBMC - CNRS UMR 7104 - Inserm U 1258 THÈSE présentée par : Kateřina JEŘÁBKOVÁ soutenue le : 09 Octobre 2019 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline/ Spécialité : Aspects moléculaires et cellulaires de la biologie Les rôles de Trim15 et UCHL3 dans la régulation, médiée par l’ubiquitine, du cycle cellulaire. The roles of Trim15 and UCHL3 in the ubiquitin-mediated cell cycle regulation. THÈSE dirigée par : Mme SUMARA Izabela PhD, Université de Strasbourg Mme CHAWENGSAKSOPHAK
    [Show full text]
  • Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis
    Getting “Under the Skin”: Human Social Genomics in the Multi-Ethnic Study of Atherosclerosis by Kristen Monét Brown A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Epidemiological Science) in the University of Michigan 2017 Doctoral Committee: Professor Ana V. Diez-Roux, Co-Chair, Drexel University Professor Sharon R. Kardia, Co-Chair Professor Bhramar Mukherjee Assistant Professor Belinda Needham Assistant Professor Jennifer A. Smith © Kristen Monét Brown, 2017 [email protected] ORCID iD: 0000-0002-9955-0568 Dedication I dedicate this dissertation to my grandmother, Gertrude Delores Hampton. Nanny, no one wanted to see me become “Dr. Brown” more than you. I know that you are standing over the bannister of heaven smiling and beaming with pride. I love you more than my words could ever fully express. ii Acknowledgements First, I give honor to God, who is the head of my life. Truly, without Him, none of this would be possible. Countless times throughout this doctoral journey I have relied my favorite scripture, “And we know that all things work together for good, to them that love God, to them who are called according to His purpose (Romans 8:28).” Secondly, I acknowledge my parents, James and Marilyn Brown. From an early age, you two instilled in me the value of education and have been my biggest cheerleaders throughout my entire life. I thank you for your unconditional love, encouragement, sacrifices, and support. I would not be here today without you. I truly thank God that out of the all of the people in the world that He could have chosen to be my parents, that He chose the two of you.
    [Show full text]
  • Receptor Signaling Through Osteoclast-Associated Monocyte
    Downloaded from http://www.jimmunol.org/ by guest on September 29, 2021 is online at: average * The Journal of Immunology The Journal of Immunology , 20 of which you can access for free at: 2015; 194:3169-3179; Prepublished online 27 from submission to initial decision 4 weeks from acceptance to publication February 2015; doi: 10.4049/jimmunol.1402800 http://www.jimmunol.org/content/194/7/3169 Collagen Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through Osteoclast-Associated Receptor Heidi S. Schultz, Louise M. Nitze, Louise H. Zeuthen, Pernille Keller, Albrecht Gruhler, Jesper Pass, Jianhe Chen, Li Guo, Andrew J. Fleetwood, John A. Hamilton, Martin W. Berchtold and Svetlana Panina J Immunol cites 43 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice option Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Freely available online through http://www.jimmunol.org/content/suppl/2015/02/27/jimmunol.140280 0.DCSupplemental This article http://www.jimmunol.org/content/194/7/3169.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Author Choice Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Network Potential Identifies Therapeutic Mirna Cocktails in Ewing Sarcoma
    bioRxiv preprint doi: https://doi.org/10.1101/854695; this version posted March 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma Davis T. Weaver1, 2, *, Kathleen I. Pishas3,*, Drew Williamson4,*, Jessica Scarborough1, 2, Stephen L. Lessnick5, Andrew Dhawan2, 6, †, and Jacob G. Scott1, 2, 7, † 1Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA 2Translational Hematology Oncology Research, Cleveland Clinic, Cleveland OH, 44106, USA 3Peter MacCallum Cancer Centre, Melbourne, Australia, 3000 4Department of Pathology, Brigham & Women’s Hospital, Boston, MA, 02144 5Nationwide Children’s Hospital, Columbus, Ohio, 43205 6Division of Neurology, Cleveland Clinic, Cleveland Ohio, 44195 7Department of Physics, Case Western Reserve University, Cleveland, OH, 44106, USA *contributed equally †[email protected], [email protected] ABSTRACT Introduction: Micro-RNA (miRNA)-based therapies are an emerging class of cancer therapies with many potential applications in the field. Because of the broad effects miRNAs can have on different cells and tissues, a network science-based approach is well-equipped to evaluate and identify miRNA candidates and combinations of candidates for the repression of key oncogenic targets. Methods: We first characterized 6 Ewing sarcoma cell lines using paired mRNA and miRNA sequencing. We then estimated a measure of tumor state, which we term network potential, based on both the mRNA gene expression and the underlying protein-protein interaction network in the tumor.
    [Show full text]
  • PP1-Associated Signaling and − B/AP-1 Κ Inhibition of NF- Tolerance
    Downloaded from http://www.jimmunol.org/ by guest on October 3, 2021 is online at: average * and − B/AP-1 κ The Journal of Immunology published online 26 February 2014 from submission to initial decision 4 weeks from acceptance to publication http://www.jimmunol.org/content/early/2014/02/26/jimmun ol.1301610 Identification of Two Forms of TNF Tolerance in Human Monocytes: Differential Inhibition of NF- PP1-Associated Signaling Johannes Günther, Nico Vogt, Katharina Hampel, Rolf Bikker, Sharon Page, Benjamin Müller, Judith Kandemir, Michael Kracht, Oliver Dittrich-Breiholz, René Huber and Korbinian Brand J Immunol Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2014/02/26/jimmunol.130161 0.DCSupplemental Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2014 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 3, 2021. Published February 26, 2014, doi:10.4049/jimmunol.1301610 The Journal of Immunology Identification of Two Forms of TNF Tolerance in Human Monocytes: Differential Inhibition of NF-kB/AP-1– and PP1-Associated Signaling Johannes Gunther,*€ ,1 Nico Vogt,*,1 Katharina Hampel,*,1 Rolf Bikker,* Sharon Page,* Benjamin Muller,*€ Judith Kandemir,* Michael Kracht,† Oliver Dittrich-Breiholz,‡ Rene´ Huber,* and Korbinian Brand* The molecular basis of TNF tolerance is poorly understood.
    [Show full text]